By Jamie Lennox ( June 8, 2026, 1:20 PM BST) -- Takeda has defended the validity of its extended patent protections for ADHD drug Elvanse, asking a London court to reject Stada's attempt to quash a U.K. supplementary protection certificate, or SPC, for the treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.